Five Star Quality Care (NYSE: FVE) is expected to report Q2 earnings on July 29. Here's what Wall Street wants to see:

The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Five Star Quality Care's revenues will increase 4.4% and EPS will grow 16.7%.

The average estimate for revenue is $364.4 million. On the bottom line, the average EPS estimate is $0.07.

Revenue details
Last quarter, Five Star Quality Care booked revenue of $360.1 million. GAAP reported sales were 1.4% higher than the prior-year quarter's $303.7 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
Last quarter, non-GAAP EPS came in at $0.02. GAAP EPS of $0.04 for Q1 were 300% higher than the prior-year quarter's $0.01 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Recent performance
For the preceding quarter, gross margin was 46.7%, 20 basis points better than the prior-year quarter. Operating margin was 0.8%, 20 basis points worse than the prior-year quarter. Net margin was 0.6%, 50 basis points better than the prior-year quarter.

Looking ahead

The full year's average estimate for revenue is $1.46 billion. The average EPS estimate is $0.25.

Investor sentiment
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 236 members out of 248 rating the stock outperform, and 12 members rating it underperform. Among 55 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 55 give Five Star Quality Care a green thumbs-up, and give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Five Star Quality Care is outperform, with an average price target of $6.93.

Is Five Star Quality Care the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.

Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.